William S. Dalton
William S. Dalton is the chair of the IHMC Board of Directors. He is also Founder and CEO of M2Gen®, a national biotechnology subsidiary of Moffitt Cancer Center. Dr. Dalton received his Ph.D. in toxicology and medical life sciences and his M.D. degree from Indiana University. He is interested in developing approaches to enhance access to health care and developing evidence-based methods of evaluating and integrating new technologies into the standard of care.
Latest News
- STEM-Talk: NASA’s Flawed Plan to Return to the Moon – with Mike Griffin and Lisa Porter
- IHMC partners with Conduit Venture Labs to accelerate commercialization efforts
- Research platforms aim to better support military personnel in high-stress environments
- Study for U.S. Air Force Research Lab tracks impact of ketones on pilot ventilation
- National Institute on Aging funded study tracks changes to gait as we age
- Meet Alex, IHMC’s next generation humanoid robot
- Decades of AI-expertise fuel growth of National Center for Collaborative Autonomy
- Entrepreneurs, researchers find opportunity at Northwest Florida Pitch Day
- IHMC honored by Humanoid Robotics Technology as Outstanding Research Organization